Logo
L

LifeMine Therapeutics

95 employees

LifeMine is a biopharmaceutical company pioneering Top-Down Drug Discovery™, a bold new approach that leverages evolutionary insights from fungi to unearth next-generation precision medicines. Through our data-immersive and technologically expansive discovery engine, we are uniquely positioned to bring mechanistically and structurally novel precision medicines to patients in urgent need of breakthrough disease intervention. LifeMine’s initial pipeline programs are focused in organ transplantation and antifungals. The Company is headquartered in Cambridge, MA, with offices in Gloucester, MA and Basel, Switzerland.

Investor insights

Funding rounds participated in

$175M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology

Sectors

Biotechnology

Date founded

2017

Funding rounds raised

Total raised

$175M

from 2 investors over 1 rounds

L

LifeMine Therapeutics raised $175M on April 23, 2022

Investors: Fidelity and + 6 Other investors

FAQ